← Back to Clinical Trials
Recruiting NCT07044076

NCT07044076 Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07044076
Status Recruiting
Phase
Sponsor Centre Hospitalier St Anne
Condition Quality of Life
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2025-06-13
Primary Completion 2025-07-13

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Quality of life

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2025-06-13 with a primary completion date of 2025-07-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Meningiomas, which account for about 40% of primary central nervous system tumors, have significant psychological and social impacts, even without treatment. Their effect on quality of life is often underestimated and poorly documented. There is one validated questionnaire (MQOL) but it has not yet been translated into French. The project involves two phases: first, translating and linguistically validating the MQOL into French; second, scientifically validating the questionnaire with 50 meningioma patients using established scales (EQ-5D, Karnofsky, FACT-Br) to ensure its reliability and internal consistency.

Eligibility Criteria

Inclusion Criteria: * Patient aged 18 years or older * Diagnosis of intracranial meningioma confirmed by imaging or surgery Exclusion Criteria: * Pregnant or breastfeeding women (Article L1121-5) * Patients deprived of liberty by judicial or administrative decision, as well as individuals undergoing psychiatric care (Article L1121-6) * Patients not fluent in French or with poor understanding of the language * Inability to refuse participation in the study

Contact & Investigator

Central Contact

Viviane AWASSI

✉ v.awassi@ghu-paris.fr

📞 01.45.65.84.86

Frequently Asked Questions

Who can join the NCT07044076 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07044076 currently recruiting?

Yes, NCT07044076 is actively recruiting participants. Contact the research team at v.awassi@ghu-paris.fr for enrollment information.

Where is the NCT07044076 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT07044076 clinical trial?

NCT07044076 is sponsored by Centre Hospitalier St Anne. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology